World Cancer Day is recognised on February 4th this year and is used to raise awareness of one of the world’s most deadly diseases. Cancer is the second-leading cause of death worldwide and up to 3.7 million lives could be saved each year by implementing resource appropriate strategie

A workshop on Medical Accelerator Design and Diagnostics was held at GSI in Darmstadt, Germany, on 10th – 12th December, 2018. Speakers discussed the latest developments in technology for beam monitoring in medical accelerators. The scientific discussions were lead by invited pl

The IET has made a series of videos to promote the Particle Accelerator Engineering Network community within the IET (co-sponsored by the IMechE Mechatronics group). The videos were shot at Daresbury and The Christie Hospital and cover 4 themes, international accelerator projects, med

The Optimization of Medical Accelerators (OMA) project, coordinated by Prof Carsten Welsch, member of the Cockcroft Institute and Head of the Liverpool Physics Department, held its 1st OMA Topical Workshop on 12th  – 13th  March 2018 at the Paul Scherrer Institute (PSI) in Switzerland

Researchers from the Cockcroft Institute organised the first scientific school of the OMA Project coordinated by CI/University of Liverpool at CNAO in Pavia, Italy between 4th – 9th June. The event gathered 75 delegates from across Europe. Along the OMA School, CNAO also hosted

5th – 9th June 2017, Fondazione CNAO,  Pavia, Italy ‌The OMA consortium is organising an international school on medical accelerators that is open for participants from within and outside the network. Renowned lecturers will complement partner expertise to cover topics such as b

    The Optimization of Medical Accelerators (OMA) started officially on 1 February 2016. OMA is an international collaboration of 31 institutions which during the four year project duration will train 15 early stage researchers in the field of particle beam therapy for canc

Cancer is a major health problem and it is the main cause of death between the ages of 45 – 65. Although significant progress has been made in the use of particle beams for cancer treatment, extensive research is still needed to maximize healthcare benefits. Improving ion beam t